{"created":"2023-06-19T06:41:42.969787+00:00","id":38,"links":{},"metadata":{"_buckets":{"deposit":"27e26238-79a7-4274-92ab-5fbf7b279157"},"_deposit":{"created_by":5,"id":"38","owners":[5],"pid":{"revision_id":0,"type":"depid","value":"38"},"status":"published"},"_oai":{"id":"oai:opcnr.repo.nii.ac.jp:00000038","sets":["1:9"]},"author_link":["156","155"],"item_10002_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2002-03","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"17","bibliographicPageStart":"9","bibliographic_titles":[{"bibliographic_title":"沖縄県立看護大学紀要"},{"bibliographic_title":"Journal of Okinawa Prefectural College of Nursing","bibliographic_titleLang":"en"}]}]},"item_10002_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"対象は再発悪性グリオーマ18例で,手術にその他の治療を行った12例をA群,手術のみを行った3例をB群,対症療法のみで腫瘍に対しては積極的な治療を行わなかった3例をC群として再発から死亡までの期間,再発から死亡までの期間に占める入院期間,再発から死亡までの期間におけるacceptable QOLの期間等を検討した.acceptable QOLはKarnofsky performance status(KS)が40%以上,Japan coma scale(JCS)I-3以上とした.その結果,再発後死亡するまでの期間にJCSI-3以上のacceptable QOLにあった割合をA群+B群とC群で比較すると,前者が有意に高かった.しかし,この経過中,入院の割合をA+B群とC群の間で比較すると有意に前者が大きかった.以上より再発性グリオーマの治療は延命効果に乏しいが,意識レベルの保持の面から評価できる.しかし延命に努力すればする程病院に縛られる期間が長くなり,一概に積極的治療がtotalな意味でacceptable QOLを保証するものではないと考えられる","subitem_description_type":"Abstract"}]},"item_10002_description_6":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"Therapy such as re-operation, radiation, chemotherapy for recurrent malignant glioma patient may provide worthwhile palliation. This study was designed to clarify the influences of these therapies over the QOL and reevaluate the therapeutic strategy for recurrent malignant glioma. 18 consecutive patients with recurrent malignant glioma were treated at University of the Ryukyus hospital. Concerning the interval between the recurrence and death, no significant difference existed between treated group and non-treated group. With respect to the QOL by JCS, proportion of acceptable QOL was greater in therapy group than no-therapy group. Whereas the ratio of hospitalization among survival time after recurrence was higher in therapy group than in no-treatment group. This means, benefit of keeping patient's consciousness in therapy group is canceled by higher percent of hospitalization among survival time after recurrence. Therefore, our data did not support the validity of therapies for the patient of recurrent malignant glioma.","subitem_description_type":"Other"}]},"item_10002_heading_23":{"attribute_name":"見出し","attribute_value_mlt":[{"subitem_heading_banner_headline":"原著","subitem_heading_language":"ja"},{"subitem_heading_banner_headline":"Original Articles","subitem_heading_language":"en"}]},"item_10002_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"沖縄県立看護大学"}]},"item_10002_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1345-5133","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"宮城, 航一"},{"creatorName":"ミヤギ, コウイチ","creatorNameLang":"ja-Kana"},{"creatorName":"Miyagi, Koichi","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"155","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"古閑, 比佐志"},{"creatorName":"コガ, ヒサシ","creatorNameLang":"ja-Kana"},{"creatorName":"Koga, Hisashi","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"156","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-03-15"}],"displaytype":"detail","filename":"No3p009.pdf","filesize":[{"value":"986.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"No3p009","url":"https://opcnr.repo.nii.ac.jp/record/38/files/No3p009.pdf"},"version_id":"5e2e5a2d-5fad-4c47-8cdd-155e30554c1c"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"腫瘍再発","subitem_subject_scheme":"Other"},{"subitem_subject":"*神経膠腫(診断,治療)","subitem_subject_scheme":"Other"},{"subitem_subject":"生活の質","subitem_subject_scheme":"Other"},{"subitem_subject":"入院期間","subitem_subject_scheme":"Other"},{"subitem_subject":"放射線療法","subitem_subject_scheme":"Other"},{"subitem_subject":"免疫療法","subitem_subject_scheme":"Other"},{"subitem_subject":"薬物療法","subitem_subject_scheme":"Other"},{"subitem_subject":"生存期間","subitem_subject_scheme":"Other"},{"subitem_subject":"ヒト","subitem_subject_scheme":"Other"},{"subitem_subject":"成人(19〜44)","subitem_subject_scheme":"Other"},{"subitem_subject":"中年(45〜64)","subitem_subject_scheme":"Other"},{"subitem_subject":"高齢者(65〜79)","subitem_subject_scheme":"Other"},{"subitem_subject":"高齢者(80〜)","subitem_subject_scheme":"Other"},{"subitem_subject":"男","subitem_subject_scheme":"Other"},{"subitem_subject":"女","subitem_subject_scheme":"Other"},{"subitem_subject":"看護","subitem_subject_scheme":"Other"},{"subitem_subject":"Glioblastoma","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Japan Coma Scale","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"malignant strocytoma","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"malignant glioma","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"quality of life","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"recurrent glioma","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Quality of lifeからみた再発グリオーマ患者の治療評価","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Quality of lifeからみた再発グリオーマ患者の治療評価"},{"subitem_title":"Quality of life and treatment of recurrent malignant glioma","subitem_title_language":"en"}]},"item_type_id":"10002","owner":"5","path":["9"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-03-15"},"publish_date":"2021-03-15","publish_status":"0","recid":"38","relation_version_is_last":true,"title":["Quality of lifeからみた再発グリオーマ患者の治療評価"],"weko_creator_id":"5","weko_shared_id":-1},"updated":"2023-06-19T06:56:07.308810+00:00"}